쉐그렌증후군과 항 갑상선 항체의 상승을 동반한 비혈관염 자가면역 염증성 뇌병증 1예
A Case of Nonvasculitic Autoimmune Inflammatory Meningoencephalitis Accompanied by Sjögren’s Syndrome and Elevated Antithyroid Antibodies
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background: Nonvasculitic autoimmune inflammatory meningoencephalitis (NAIM) is known to be one of the causes of potentially reversible dementia. NAIM can be accompanied by various autoimmune diseases. Methods: A 65 year-old woman had been treated with stable bipolar disorder and presented with rapid cognitive decline, visual hallucination and myoclonus. Anti-thyroid antibodies were elevated. Her symptoms were responsive to steroid therapy. Her diagnostic evaluation also revealed Sjögren’s syndrome. Although her symptoms recovered, a manic episode reappeared and was responsive to psychiatric treatment. Conclusions: Patients presenting with rapidly progressive dementia should be thoroughly evaluated for the diagnosis of NAIM, a potentially treatable form of dementia, and the possible various underlying autoimmune etiologies.
Abstract
Background: Nonvasculitic autoimmune inflammatory meningoencephalitis (NAIM) is known to be one of the causes of potentially reversible dementia. NAIM can be accompanied by various autoimmune diseases. Methods: A 65 year-old woman had been treated with stable bipolar disorder and presented with rapid cognitive decline, visual hallucination and myoclonus. Anti-thyroid antibodies were elevated. Her symptoms were responsive to steroid therapy. Her diagnostic evaluation also revealed Sjögren’s syndrome. Although her symptoms recovered, a manic episode reappeared and was responsive to psychiatric treatment. Conclusions: Patients presenting with rapidly progressive dementia should be thoroughly evaluated for the diagnosis of NAIM, a potentially treatable form of dementia, and the possible various underlying autoimmune etiologies.
참고문헌 (11)
- Caselli RJ, "Nonvasculitic autoimmune inflammatory meningoencephalitis (NAIM): a reversible form of encephalopathy", Neurology, 53, pp.1579~1581 (1999)
- Castillo P, "Steroid-responsive encephalopathy associated with autoimmune thyroiditis", Arch Neurol, 6, pp.197~202 (2006)
- Brain L, "Hashimoto’s disease and encephalopathy", Lancet, 2, pp.512~514 (1966)
- Geschwind MD, "Rapidly progressive dementia", Ann Neurol, 64, pp.97~108 (2008)
- Ozgocmen S, "Treatment of central nervous system involvement associated with primary Sjögren’s syndrome", Curr Pharm Des, 14, pp.1270~1273 (2008)
- Delalande S, "Neurologic manifestations in primary Sjogren syndrome: a study of 82 patients", Medicine, 83, pp.280~291 (2004)
- Caselli RJ, "The treatable dementia of Sjögren’s syndrome", Ann Neurol, 30, pp.98~101
- Tan EM, "The 1982 revised criteria for the classification of systemic lupus erythematosus", Arthritis Rheum, 25, pp.1271~1277 (1982)
- Vitali C, "Classification criteria for Sjögren’s syndrome: a revised version of the European criteria proposed by the American-European criteria proposed by the American-European Consensus Group", Ann Rheum Dis, 61, pp.554~558 (2002)
- Josephs KA, "Nonvasculitic autoimmune inflammatory meningoencephalitis", Neuropathology, 24, pp.149~152 (2004)
- Lyons MK, "Nonvasculitic autoimmune inflammatory meningoencephalitis as a cause of potentially reversible dementia: report of 4 cases", J Neurosurg, 108, pp.1024~1027 (2008)
